| Patents for A61P 5 - Drugs for disorders of the endocrine system (28,908) |
|---|
| 01/29/2014 | EP2688891A1 Benzoxazepin compounds selective for pi3k p110 delta and methods of use |
| 01/29/2014 | CN103547563A Biphenyl derivatives useful as glucagon receptor antagonists |
| 01/29/2014 | CN103547274A Biological inorganic compound complex having reduced oxygen and high reducing ability |
| 01/29/2014 | CN103539791A Modulators of the GPR119 receptor and the treatment of disorders related thereto |
| 01/29/2014 | CN103539760A Phenoxy phenylacetic acid endothelin antagonist, and preparation method and application thereof |
| 01/29/2014 | CN103539659A 2,4-dibenzyloxybenzoic acid derivative and preparation method and application thereof |
| 01/29/2014 | CN103536748A Traditional Chinese medicament for treating goiter with depression of liver to generate pathogenic fire |
| 01/29/2014 | CN103536694A Traditional Chinese medicine composition for treating hyperthyroidism merger leukopenia |
| 01/29/2014 | CN102772417B Period effect percutaneous patch of self viscosity elastic body substrate containing testosterone and preparation method thereof |
| 01/29/2014 | CN102481368B Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast |
| 01/29/2014 | CN101835779B Purine derivatives useful as PI3 kinase inhibitors |
| 01/29/2014 | CN101744989B Method for extracting schisandra chinensis, ginseng and dwarf lilyturf root and preparation thereof |
| 01/23/2014 | WO2014014530A1 Ursolic acid salts for treating diabetes and obesity |
| 01/22/2014 | EP2687532A1 Novel octahydrothienoquinoline derivative, pharmaceutical composition comprising derivative, and use of these |
| 01/22/2014 | EP2687215A1 Mesterolone pharmaceutical composition for androgens' deficiencies in woman |
| 01/22/2014 | EP2686333A2 Isoxazolidine derivatives |
| 01/22/2014 | EP2686332A2 Isoxazolidine derivatives |
| 01/22/2014 | EP2686306A1 Benzo [b][1, 4]oxazin derivatives as calcium sensing receptor modulators |
| 01/22/2014 | EP2685989A1 Combination of anti-clusterin oligonucleotide with androgen receptor antagonist for the treatment of prostate cancer |
| 01/22/2014 | CN103525900A Nucleic acid suppression molecule for suppressing expression of brain eIF6 gene and screening method and application thereof |
| 01/22/2014 | CN103524599A Cyclopeptide luteinizing hormone releasing hormone (LHRH) antagonist derivatives and pharmaceutical use thereof |
| 01/22/2014 | CN103524466A Dihydrobenzofuran derivative as well as preparation method, intermediate and application thereof |
| 01/22/2014 | CN103520703A Application of eIF6 in detection, prevention or treatment of exercise-induced fatigue or memory loss |
| 01/22/2014 | CN103520200A Composition containing ophiopogon japonicus polysaccharide MDG-1 and application of composition in preparation of medicament or healthcare product for improving metabolic syndromes |
| 01/22/2014 | CN103520158A Contains pioglitazone oral formulation |
| 01/22/2014 | CN103520135A Resveratrol-supporting poly(lactic-co-glycolic acid) micro-nano particles and preparation method thereof |
| 01/21/2014 | US8633210 Triazole compounds useful as protein kinase inhibitors |
| 01/21/2014 | US8633159 Apparatus and method for transdermal delivery of parathyroid hormone agents |
| 01/21/2014 | CA2628747C Combinations of hormone therapy agents and metalloprotease inhibitors for the treatment of cancer |
| 01/21/2014 | CA2371995C Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 01/16/2014 | WO2014009274A1 3-substituted estra-1,3,5(10),16-tetraene derivatives, methods for the production thereof, pharmaceutical preparations containing same, and use thereof for the production of medicaments |
| 01/15/2014 | EP2684565A1 Use of ulipristal acetate for treating uterine fibroids |
| 01/15/2014 | EP2683697A1 Substituted morpholines as modulators for the calcium sensing receptor |
| 01/15/2014 | EP2683694A1 Androgen receptor antagonists and uses thereof |
| 01/15/2014 | EP2683410A2 Targeted nanocarrier systems for delivery of actives across biological membranes |
| 01/15/2014 | CN103505743A Cell micro-particles containing functional microRNA/siRNA and application thereof |
| 01/15/2014 | CN103505666A Traditional Chinese medicine used for treating hyperthyroidism |
| 01/15/2014 | CN103505619A Traditional Chinese medicine composition used for treating hyperthyroidism |
| 01/15/2014 | CN103505449A Application of N-acetylcysteine in preparation of drugs for preventing and treating DNA damage and tissue damage induced by synchrotron radiation |
| 01/14/2014 | US8629103 Treatment of non-proliferative cystic disease of the breast |
| 01/14/2014 | US8629102 3-hydroxyisothiazole 1-oxide derivatives |
| 01/14/2014 | CA2569678C Regulator of physiological function of ghrelin and use thereof |
| 01/09/2014 | WO2014007228A1 Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes |
| 01/09/2014 | WO2014005858A1 Use of long-acting glp-1 peptides |
| 01/09/2014 | WO2014005513A1 Cyclopeptide lhrh antagonist derivatives and pharmacal use thereof |
| 01/09/2014 | WO2014005274A1 Multi-substituted 8-nitrogen heterocyclic ring [3.2.1] octane compound |
| 01/09/2014 | US20140011788 Pharmaceutical composition and method for treating hypogonadism |
| 01/09/2014 | US20140011754 Crystalline form of benzylbenzene sglt2 inhibitor |
| 01/09/2014 | US20140011215 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays |
| 01/09/2014 | US20140010798 Albumin fusion proteins |
| 01/09/2014 | CA2877056A1 Use of long-acting glp-1 peptides |
| 01/08/2014 | EP2682123A2 Biologically active food additive for normalizing the function of the thyroid gland |
| 01/08/2014 | EP2682122A1 Growth hormone secretion promoter |
| 01/08/2014 | EP2680871A2 Parathyroid hormone analogs, compositions and uses thereof |
| 01/08/2014 | EP2680862A1 Encapsulated cells for hormone replacement therapy |
| 01/08/2014 | CN103501821A Targeted nanocarrier systems for delivery of actives across biological membranes |
| 01/08/2014 | CN103501801A Parathyroid hormone analogs, compositions and uses thereof |
| 01/08/2014 | CN103497188A Compounds modulating c-fms and/or c-kit activity and uses therefor |
| 01/08/2014 | CN103497181A Benzoperhydroazepinone compounds as glycogen phosphorylase inhibitors as well as preparation method and medical application thereof |
| 01/08/2014 | CN103495055A Traditional Chinese medicine decoction for treating female endocrine disorders and preparation method thereof |
| 01/08/2014 | CN103494194A Novel formula and production technology of drone, ginseng and pseudo-ginseng capsule product |
| 01/08/2014 | CN101116666B Compositions of estrogen-cyclodextrin complexes |
| 01/07/2014 | US8623833 Compositions and methods for enhancing drug delivery across and into epithelial tissues |
| 01/07/2014 | CA2780732C Androgen receptor modulator and uses thereof |
| 01/07/2014 | CA2453967C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 01/03/2014 | WO2014001377A1 5-azaindazole compounds and methods of use |
| 01/03/2014 | WO2014000629A1 Hexahydropentaleno derivatives, preparation method and use in medicine thereof |
| 01/03/2014 | CA2877167A1 Oxabicycloheptanes and oxabicycloheptenes for the treatment of diabetes |
| 01/02/2014 | US20140005106 Method for administering glp-1 molecules |
| 01/02/2014 | US20140004095 Albumin fusion proteins |
| 01/01/2014 | EP2679681A1 Fc riib-specific fc antibody |
| 01/01/2014 | EP2679228A1 Therapy using vitamin D repletion agent and vitamin D hormone replacement agent |
| 01/01/2014 | EP2678017A2 Asymmetric ureas and medical uses thereof |
| 01/01/2014 | CN103492565A FcgRIIb-specific Fc antibody |
| 01/01/2014 | CN103483317A Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme |
| 01/01/2014 | CN103483234A Cyclopropyl amine derivatives |
| 01/01/2014 | CN103479859A Traditional Chinese medicine composition for treating hyperandrogenism of polycystic ovary syndrome |
| 01/01/2014 | CN103479845A Method for preparing freeze-dried powder injection promoting estrogen secretion from aloes and pseudo-ginseng |
| 01/01/2014 | CN103479744A Traditional Chinese medicine composition with functions of soothing liver and maintaining beauty |
| 01/01/2014 | CN102988395B Application of Houttuynoid E in preparation of medicine for promoting insulin secretion |
| 01/01/2014 | CN102988385B Application of Houttuynoid A to preparation of medicine for treating osteoporosis caused by lack of antiestrogen |
| 01/01/2014 | CN102698025B Traditional Chinese medicine preparation for treating female endocrine dyscrasia and preparation method thereof |
| 01/01/2014 | CN101801375B Insulin sensitisers and methods of treatment |
| 12/31/2013 | US8618174 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 12/31/2013 | US8618045 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof, and method for preparing same |
| 12/31/2013 | CA2629018C Aza-substituted spiro derivative |
| 12/27/2013 | CA2876977A1 Natural combination hormone replacement formulations and therapies |
| 12/26/2013 | US20130345180 2,4- diaminopyrimidine derivatives |
| 12/25/2013 | EP2455371B1 4-(3-butynyl)aminopyrimidine derivatives as pest control agents for agricultural and horticultural use |
| 12/25/2013 | EP2086539B1 Selective glycosidase inhibitors |
| 12/25/2013 | CN103468407A Plant essential oil composition and bra |
| 12/25/2013 | CN103463540A Traditional Chinese medicine effective part composition for treatment of Sheehan's syndrome |
| 12/25/2013 | CN103463077A Application of Lycojaponicumin C in medicine for promoting insulin secretion |
| 12/25/2013 | CN103463038A Application of Lycojaponicumin A in insulinotropic hormone excretion medicaments |
| 12/25/2013 | CN103463031A Application of Lycojaponicumin B in medicine for promoting insulin secretion |
| 12/25/2013 | CN103462965A Application of Incarviatone A in insulinotropic hormone excretion medicaments |
| 12/25/2013 | CN103462946A New applications of protocatechuic acid in preparing medicaments |
| 12/24/2013 | US8613920 Treatment of amyloidogenic diseases |
| 12/19/2013 | WO2013187466A1 Branched chain alkyl heteroaromatic ring derivative |
| 12/19/2013 | CA2876249A1 Branched chain alkyl heteroaromatic ring derivative |